ATE454467T1 - Verwendung des slug-gens oder der transkriptions- oder expressionsprodukte davon beim nachweis und/oder bei der behandlung von krebsartigen zellen - Google Patents
Verwendung des slug-gens oder der transkriptions- oder expressionsprodukte davon beim nachweis und/oder bei der behandlung von krebsartigen zellenInfo
- Publication number
- ATE454467T1 ATE454467T1 AT02710865T AT02710865T ATE454467T1 AT E454467 T1 ATE454467 T1 AT E454467T1 AT 02710865 T AT02710865 T AT 02710865T AT 02710865 T AT02710865 T AT 02710865T AT E454467 T1 ATE454467 T1 AT E454467T1
- Authority
- AT
- Austria
- Prior art keywords
- transcription
- cells
- expression products
- cancerical
- treating
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57505—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the blood, e.g. leukaemia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200100151A ES2185472B1 (es) | 2001-01-23 | 2001-01-23 | Empleo del gen slug, o de sus productos de transcripcion o expresion, en la deteccion y/o tratamiento de celulas cancerosas. |
| PCT/ES2002/000026 WO2002059361A1 (es) | 2001-01-23 | 2002-01-23 | Empleo del gen slug o de sus productos de transcripcion o expresion en la deteccion y/o tratamiento de celulas cancerosas |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE454467T1 true ATE454467T1 (de) | 2010-01-15 |
Family
ID=8496481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02710865T ATE454467T1 (de) | 2001-01-23 | 2002-01-23 | Verwendung des slug-gens oder der transkriptions- oder expressionsprodukte davon beim nachweis und/oder bei der behandlung von krebsartigen zellen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7776519B2 (de) |
| EP (1) | EP1354962B1 (de) |
| JP (1) | JP2004520045A (de) |
| AT (1) | ATE454467T1 (de) |
| DE (1) | DE60234991D1 (de) |
| ES (4) | ES2185472B1 (de) |
| WO (1) | WO2002059361A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2195751B1 (es) | 2001-11-27 | 2005-04-01 | Universidad De Salamanca (Otri) | Mamiferos no humanos transgenicos como modelos para patologias humanas con origen en celulas stem. |
| ES2253028B1 (es) * | 2003-05-30 | 2007-08-01 | Universidad De Salamanca | "empleo del gen slug, sus productos de transcripcion o expresion, y/o compuestos inhibidores o estimuladores de la expresion de slug para conferir radioresistencia o radioproteccion celular. |
| ES2301268B1 (es) * | 2004-10-25 | 2009-05-01 | Centro De Investigacion Biomolecular Aplicada Salamanca, S.L. | Empleo del gen slug, o de sus productos de replicacion, transcripcion o expresion, en la identificacion, diagnostico, prevencion o tratamiento de la diseminacion del cancer y/o desarrollo de metastasis. |
| CA2656548A1 (en) * | 2005-06-30 | 2007-01-11 | Whitehead Institute | Progenitor cells and uses thereof |
| US20110302665A1 (en) * | 2008-07-02 | 2011-12-08 | Oktay Kirak | Non-human mammals with t or b cells having predefined specificity |
| KR101805181B1 (ko) | 2016-09-02 | 2017-12-07 | 충북대학교 산학협력단 | 인산화된 slug 단백질의 유사분열 세포에 대한 신규한 바이오 마커로서의 용도 |
| EP4457341A1 (de) * | 2021-12-30 | 2024-11-06 | Mestastop Solutions Private Limited | Verfahren zur herstellung eines spontanen metastasemodells |
| CN116747309B (zh) * | 2023-06-20 | 2025-12-05 | 中山大学 | Slug抑制剂在制备华支睾吸虫细胞外囊泡诱导的胆管癌的治疗药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| EP2481814A3 (de) * | 2003-06-09 | 2012-10-10 | The Regents of the University of Michigan | Zusammensetzungen und Verfahren zur Behandlung und Diagnose von Krebs |
-
2001
- 2001-01-23 ES ES200100151A patent/ES2185472B1/es not_active Expired - Fee Related
-
2002
- 2002-01-23 DE DE60234991T patent/DE60234991D1/de not_active Expired - Lifetime
- 2002-01-23 JP JP2002559843A patent/JP2004520045A/ja active Pending
- 2002-01-23 EP EP20020710865 patent/EP1354962B1/de not_active Expired - Lifetime
- 2002-01-23 WO PCT/ES2002/000026 patent/WO2002059361A1/es not_active Ceased
- 2002-01-23 ES ES02710865T patent/ES2339335T3/es not_active Expired - Lifetime
- 2002-01-23 US US10/466,817 patent/US7776519B2/en not_active Expired - Fee Related
- 2002-01-23 AT AT02710865T patent/ATE454467T1/de not_active IP Right Cessation
- 2002-11-15 ES ES200202634A patent/ES2242469B1/es not_active Expired - Fee Related
- 2002-11-15 ES ES200202633A patent/ES2241402B1/es not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004520045A (ja) | 2004-07-08 |
| ES2242469A1 (es) | 2005-11-01 |
| DE60234991D1 (de) | 2010-02-25 |
| ES2185472A1 (es) | 2003-04-16 |
| ES2339335T3 (es) | 2010-05-19 |
| ES2185472B1 (es) | 2004-10-16 |
| ES2242469B1 (es) | 2006-07-16 |
| EP1354962A1 (de) | 2003-10-22 |
| EP1354962B1 (de) | 2010-01-06 |
| ES2241402B1 (es) | 2007-02-16 |
| US20060141454A1 (en) | 2006-06-29 |
| US7776519B2 (en) | 2010-08-17 |
| ES2241402A1 (es) | 2005-10-16 |
| WO2002059361A1 (es) | 2002-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE454468T1 (de) | Nachweis der instabilität von mikrosatelliten und verwendung davon bei der tumordiagnose | |
| NZ593289A (en) | Anti-neuropilin-1 antibodies for treating angiogenesis | |
| DE69503129D1 (de) | Pteridin-nukleotidderivate als fluoreszierende sonden | |
| ATE337011T1 (de) | Modifizierte psma-liganden und deren verwendung | |
| PT991421E (pt) | Deteccao e modulacao das iap e naip para o diagnostico e tratamento de doenca proliferativa | |
| WO2005084109A3 (en) | Cancer specific gene mh15 | |
| NO20024240D0 (no) | Nye arylfruktose-1,6-bisfosfataseinhibitorer | |
| AU2003293141A8 (en) | Methods for identifying risk of breast cancer and treatments thereof | |
| DE60234991D1 (de) | Verwendung des slug-gens oder der transkriptions- oder expressionsprodukte davon beim nachweis und/oder bei der behandlung von krebsartigen zellen | |
| WO2002022879A3 (en) | Detection of microsatellite instability and its use in diagnosis of tumors | |
| DE602004015626D1 (de) | Bei brustkrebs | |
| WO2003025141A3 (en) | Genetic analysis for stratification of cancer risk | |
| DE60027045D1 (de) | Oligonukleotide und diese enthaltende komplexe zur detektion der anwesenheit oder abwesenheit einer zielnukleinsäure in einer probe | |
| WO2002031209A3 (en) | Genes related to development of refractory prostate cancer | |
| AU2003264078A8 (en) | Method for analyzing body fluids for the presence of cancer cells, use thereof, corresponding analysis kits, and use of specific active substances for treating cancer | |
| MXPA05014220A (es) | Genes regulados en cancer ovarico como objetivos de pronostico y terapeuticos. | |
| ATE531529T1 (de) | Wertdokument, herstellung und prüfung von wertdokumenten | |
| WO2005014846A3 (en) | Methods for identifying risk of breast cancer and treatments thereof | |
| ATE229571T1 (de) | Nachweis und identifizierung von nicht-polio enteroviren | |
| WO2003030725A3 (en) | Pancreatic cancer diagnosis and therapies | |
| WO2005024067A3 (en) | Genetic analysis for stratification of breast cancer risk | |
| ATE333521T1 (de) | Detektion von vancomycin-resistenten enterococcus-subspezies | |
| WO2003062826A3 (en) | Materials and methods for examining and treating nasopharyngeal carcinoma | |
| WO2002044419A3 (en) | Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer | |
| WO2004048546A3 (en) | Methods for identifying risk of breast cancer and treatments thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |